BusinessDay
Nigeria's leading finance and market intelligence news report.

Pfizer’s covid-19 vaccine candidate Shows Promise in Test As Global cases top 10.5m

An early trial of an experimental coronavirus vaccine from Pfizer Inc. and BioNtech SE showed it’s safe and prompted patients to produce antibodies against the new virus, keeping it in the lead pack for a pandemic shot. The messenger RNA product was tested on 45 healthy adults divided in several groups: 24 of them got…

Don’t miss another story

Become a BusinessDay Subscriber today.

For insights, facts, figures, and access to opportunities.
Options starting from N1000 Monthly
Already a subsriber?
Whatsapp mobile

Get real time updates directly on you device, subscribe now.

Comments are closed.